Autoreactive B cells play a key role in the pathogenesis of systemic lupus erythematosus (SLE).
The aim of this study is to assess the safety of allogeneic chimeric antigen receptor (CAR)-T cells for patients with lupus.
This study was registered at ClinicalTrials.gov (NCT05859997).
